Executive order on prescription drug pricing supports key drug industry efforts to weaken the Medicare negotiation program.

President Trump was talking to reporters Friday after Dr. Oz's swearing-in ceremony when the news conference abruptly ended.

Seeking Alpha analyst Stephen Ayers shares his views on which weight-loss drug stock looks most attractive for investors ...

Like tens of thousands of Massachusetts residents, community college professor Carolyn McGrath has been paying for medicine ...

President Donald Trump’s executive order paved the way for Medicare to negotiate drug prices and brought real reform to the process. If successful, this ...

Unfortunately, doctors had no say in which medicines were selected. And they’ll have almost no input into the negotiation process unless changes are made to policies in force at the Centers for ...

President Donald Trump has signed an Executive Order aimed at lowering drug prices and reducing Medicare costs.

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Federal officials recently selected 15 medicines — including several revolutionary weight-loss injections, four cancer ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on Tuesday aimed at lowering drug prices and reducing costs for Medicare. The move ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

The coverage would have made millions more eligible for treatments at a time when weight loss drugs are becoming more and ...